Cipla gets 6 USFDA observations for Maha facility Ruchika Sharma5 April 2024 11:51 AM ISTMumbai: Cipla has received six inspectional observations in Form 483 from the United States Food and Drug Administration (USFDA) at the...
Lupin names Dr Ranjana Pathak as Chief Quality Officer Ruchika Sharma3 April 2024 5:36 PM ISTMumbai: Global pharma major Lupin Limited today announced the appointment of Dr Ranjana Pathak as Chief Quality Officer, succeeding Johnny Mikell...
Cipla Gets CDSCO Panel Nod To import, market Human Insulin inhalation powder with inhaler Dr. Divya Colin31 March 2024 5:00 PM ISTNew Delhi: Pharmaceutical major Cipla has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi, Cipla collaborate to expand Central Nervous System portfolio reach in India Ruchika Sharma28 March 2024 4:48 PM ISTMumbai: Sanofi India Limited and Sanofi Healthcare India Private Limited, and Cipla Limited have announced an exclusive partnership for...
Cipla gets CDSCO nod to market novel antibiotic Plazomicin in India, to launch under brand name Zemdri Ruchika Sharma5 March 2024 12:11 PM ISTMumbai: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic...
USFDA concludes inspection at Cipla Qidong facility with zero observations Ruchika Sharma2 March 2024 12:29 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has concluded a pre-approval inspection with zero Form 483...
CDSCO Panel grants Cipla's Prescribing Information update for Bovine Lipid Extract Surfactant Suspension Dr. Divya Colin22 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions Ruchika Sharma22 Feb 2024 2:27 PM IST"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...
Indian Pharmaceutical Market soars with 9.5% growth in January 2024: Pharmarack Report Farhat Nasim20 Feb 2024 5:56 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) exhibited a robust growth of 9.5% in terms of value and 2.07% in units, reaching a total value of...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
Cipla, CSIR-CDRI to jointly develop novel ophthalmic formulation for fungal keratitis Ruchika Sharma16 Feb 2024 12:30 PM ISTMumbai: Cipla Limited has announced that the company has entered into a collaborative research agreement with CSIR-Central Drug Research Institute...
Cipla eyes inorganic partnerships, acquisitions in US Ruchika Sharma5 Feb 2024 3:30 PM ISTCipla MD and CEO Umang Vohra said that "derisking our top launches remains our top priority" as the company focuses on resolving regulatory issues at...
